These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 1359736
1. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users. Rezza G, Titti F, Pezzotti P, Sernicola L, Lo Caputo S, Angarano G, Lazzarin A, Sinicco A, Rossi GB, Verani P. J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736 [Abstract] [Full Text] [Related]
2. Serum IgD behaviour in HIV-1 infected patients. Raiteri R, Albonico M, Deiana R, Marietti G, Sinicco A. Allergol Immunopathol (Madr); 1991; 19(1):6-10. PubMed ID: 1950942 [Abstract] [Full Text] [Related]
3. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV. N Engl J Med; 1990 Jan 18; 322(3):166-72. PubMed ID: 1967191 [Abstract] [Full Text] [Related]
4. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. Zagury JF, Sill A, Blattner W, Lachgar A, Le Buanec H, Richardson M, Rappaport J, Hendel H, Bizzini B, Gringeri A, Carcagno M, Criscuolo M, Burny A, Gallo RC, Zagury D. J Hum Virol; 1998 Jan 18; 1(4):282-92. PubMed ID: 10195253 [Abstract] [Full Text] [Related]
5. Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsets. Andrieu JM, Eme D, Venet A, Audroin C, Tourani JM, Stern M, Israel-Biet D, Beldjord K, Driss F, Even P. Clin Exp Immunol; 1988 Jul 18; 73(1):1-5. PubMed ID: 3262463 [Abstract] [Full Text] [Related]
6. Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women. Jackson JB, Kataaha P, Hom DL, Mmiro F, Guay L, Ndugwa C, Marum L, Piwowar E, Brewer K, Toedter G. AIDS; 1993 Nov 18; 7(11):1475-9. PubMed ID: 8280414 [Abstract] [Full Text] [Related]
7. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine. Crocchiolo PR, Lizioli A, Arcidiacono I, Cantaluppi P, Filippi C, Sobatti D, Bedarida G, D'Agostino F, Cambie G, Nardella ML. Boll Ist Sieroter Milan; 1990 Jun 18; 69(2):423-30. PubMed ID: 1983798 [Abstract] [Full Text] [Related]
8. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul 18; 8(7):911-21. PubMed ID: 7946100 [Abstract] [Full Text] [Related]
9. Serum B2-microglobulin and human immunodeficiency virus infection in intravenous drug users: a cross-sectional study. De Mercato R, Rezza G, Giuliani M, Perna E, Iovinella V, Bassi A, Tagliaferro R. Boll Ist Sieroter Milan; 1990 Jun 18; 69(2):447-8. PubMed ID: 2152304 [Abstract] [Full Text] [Related]
10. Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection. Jiao Y, Li TS, Xie J, Han Y, Qiu ZF, Zuo LY, Mourez T, Wang AX. Chin Med J (Engl); 2006 Oct 05; 119(19):1609-15. PubMed ID: 17042973 [Abstract] [Full Text] [Related]
11. [The prognostic markers of HIV infection progression. A study of the p24 antigen in a cohort of 251 patients]. Rubio Caballero M, Nogués Biau A, Falguera Sacrest M, Puig Ganau T. An Med Interna; 1999 Sep 05; 16(9):447-50. PubMed ID: 10609356 [Abstract] [Full Text] [Related]
12. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection]. Sorice F, Vullo V, Cirelli A, Catania S, Mastroianni CM, Contini C, Delia S. Boll Ist Sieroter Milan; 1989 Sep 05; 68(2):115-21. PubMed ID: 2562362 [Abstract] [Full Text] [Related]
13. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients]. Vial PA, Ferreccio C, Abarca K, Ortiz E, Noriega M, Pérez C, Labarca J, Torres M, Ferrés M, González C, Acuña G. Rev Med Chil; 1996 May 05; 124(5):525-35. PubMed ID: 9035503 [Abstract] [Full Text] [Related]
14. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS]. Halota W, Jaruga B, Pawłowska M. Pol Merkur Lekarski; 2002 Aug 05; 13(74):126-8. PubMed ID: 12420343 [Abstract] [Full Text] [Related]
15. [Estimated biological markers of progression in human immunodeficiency virus infection]. Bélec L, Ripoll L, Matta F, Mbopi Kéou FX, Cotigny S, Longuet MF, Jacob A. Ann Biol Clin (Paris); 1992 Aug 05; 50(9):621-37. PubMed ID: 1298168 [Abstract] [Full Text] [Related]
16. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, White GC, Drummond JE, Vaidya K, Mann DL, Eyster ME. N Engl J Med; 1989 Oct 26; 321(17):1141-8. PubMed ID: 2477702 [Abstract] [Full Text] [Related]
17. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF. Clin Immunol; 2001 Feb 26; 98(2):212-9. PubMed ID: 11161977 [Abstract] [Full Text] [Related]
20. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients]. Rubio Caballero M, Nogués Biau A, Falguera Sacrest M, Puig Ganau T, Lecha N, Rubio Rivas C. An Med Interna; 2000 Oct 26; 17(10):533-7. PubMed ID: 11109648 [Abstract] [Full Text] [Related] Page: [Next] [New Search]